Historically, US clinical trials have been shown to recruit disproportionately large percentages of White patients, raising concerns about the generalizability of clinical trial results to underrepresented racial minority patient populations. Because of this, the FDA has recently reiterated its guidance stating that clinical trials need to reflect the demographic distribution of the US.

Please watch this pre-recorded event hosted by Clinical Leader with the Medidata AI team as we walk through an analysis of clinical trial data from an industry-leading historical clinical trial data repository, delving into racial disparities across therapeutic areas.

You will learn:
– The current status of racial diversity in US trials
– Explain how various insights can be derived by looking at more granular data

Who Should Watch the webinar:
-Chief Diversity Officers (whose mandate includes assessing and improving diversity within the organization)
-Clinical Operations (study feasibility / trial planning)
-Business Development Teams